Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
111M
-
Number of holders
-
983
-
Total 13F shares, excl. options
-
105M
-
Shares change
-
-2.58M
-
Total reported value, excl. options
-
$19.9B
-
Value change
-
-$469M
-
Put/Call ratio
-
1.11
-
Number of buys
-
454
-
Number of sells
-
-422
-
Price
-
$190.58
Significant Holders of QUEST DIAGNOSTICS INC - COMMON STOCK (DGX) as of Q3 2025
1,096 filings reported holding DGX - QUEST DIAGNOSTICS INC - COMMON STOCK as of Q3 2025.
QUEST DIAGNOSTICS INC - COMMON STOCK (DGX) has 983 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 105M shares
of 111M outstanding shares and own 94.32% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14.3M shares), BlackRock, Inc. (10M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.01M shares), STATE STREET CORP (5.22M shares), JPMORGAN CHASE & CO (4.32M shares), Boston Partners (4.04M shares), GEODE CAPITAL MANAGEMENT, LLC (3.04M shares), VICTORY CAPITAL MANAGEMENT INC (2.34M shares), MORGAN STANLEY (2.29M shares), and DIMENSIONAL FUND ADVISORS LP (1.91M shares).
This table shows the top 983 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.